PBE vs. RSPH: Is a Biotech ETF or Equal-Weight Healthcare ETF the Better Choice for Investors?

Key Points PBE offers a higher dividend yield and has delivered stronger one-year total returns. RSPH offers a more affordable expense ratio and a significantly lower historical drawdown. The two funds differ in their scope and diversification, which can appeal to different investing goals. 10 stocks we like better than Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight Health Care ETF › Healthcare investors often choose between targeting high-growth sub-sectors or capturing the broader market. The Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) provides a concentrated approach to the biotech industry, while the Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) offers broader exposure with lower volatility.